Adverse event | Grade I/II (%) | Grade III/IV (%) | ||||
---|---|---|---|---|---|---|
TKIs (n = 90) | TKIs + SBRT (n = 45) | p | TKIs (n = 90) | TKIs + SBRT (n = 45) | p | |
Rash | 37 (41.1%) | 20 (44.4%) | 0.712 | 8 (8.9%) | 3 (6.7%) | 0.656 |
Diarrhea | 26 (28.9%) | 14 (31.1%) | 0.790 | 0 (0.0%) | 0 (0.0%) | |
Dry skin | 26 (28.9%) | 11 (24.4%) | 0.585 | 0 (0.0%) | 0 (0.0%) | |
Paronychia | 17 (18.9%) | 8 (17.8%) | 0.876 | 2 (2.2%) | 0 (0.0%) | 0.552 |
Mucositis | 19 (21.1%) | 9 (20.0%) | 0.881 | 0 (0.0%) | 0 (0.0%) | |
Anorexia | 13 (14.4%) | 6 (13.3%) | 0.861 | 0 (0.0%) | 0 (0.0%) | |
Elevated aminotransferase | 23 (25.6%) | 14 (31.1%) | 0.495 | 6 (6.7%) | 4 (8.9%) | 0.642 |
Nausea or vomiting | 8 (8.9%) | 6 (13.3%) | 0.425 | 0 (0.0%) | 0 (0.0%) | |
Interstitial pneumonia | 3 (3.3%) | 1 (2.2%) | 0.858 | 0 (0.0%) | 0 (0.0%) | |
Radiation pneumonitis | 0 (0.0%) | 15 (33.3%) | < 0.001 | 0 (0.0%) | 2 (4.4%) | 0.109 |
Radiation esophagitis | 0 (0.0%) | 3 (6.7%) | 0.035 | 0 (0.0%) | 0 (0.0%) | |
Fatigue | 7 (7.8%) | 14 (31.1%) | < 0.001 | 0 (0.0%) | 0 (0.0%) | |
Radiation dermatitis | 0 (0.0%) | 5 (11.1%) | 0.004 | 0 (0.0%) | 0 (0.0%) |